Sana Biotechnology, Inc. — Investor Relations & Filings
Filings indexed
363
across all filing types
Latest filing
2024-02-29
Earnings Release
Country
US
United States of America
Listing
US
SANA
Sana Biotechnology, Inc. is a company that develops engineered cells as medicines to address the underlying causes of disease. Its core strategy involves two primary platforms: in vivo therapies designed to repair and control genes within a patient's existing cells, and ex vivo therapies that replace missing or damaged cells with new, functional ones. The company utilizes proprietary technologies, such as engineered fusogen proteins, for the targeted delivery of therapeutics. Sana's pipeline is focused on advancing drug candidates for a range of diseases, including diabetes, B-cell cancers, and B-cell related autoimmune disorders.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2024-02-29 | English | |
| SC 13G/A | 2024-02-14 | English | |
| 4 | 2024-02-14 | English | |
| 3 | 2024-02-14 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-02-12 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-02-12 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 13168274 | 8-K | 2024-02-29 | English | ||
| 13168275 | SC 13G/A | 2024-02-14 | English | ||
| 13168276 | 4 | 2024-02-14 | English | ||
| 13168277 | 3 | 2024-02-14 | English | ||
| 13168278 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-02-12 | English | ||
| 13168279 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-02-12 | English | ||
| 13168280 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-02-12 | English | ||
| 13168282 | ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#2) | 2024-02-09 | English | ||
| 13168281 | Major Shareholding Notification 2024 | 2024-02-09 | English | ||
| 13168283 | 8-K | 2024-02-08 | English | ||
| 13168286 | 424B5 | 2024-02-08 | English | ||
| 13168285 | FWP | 2024-02-08 | English | ||
| 13168287 | 424B5 | 2024-02-07 | English | ||
| 13168288 | 8-K | 2024-02-07 | English | ||
| 13168289 | Major Shareholding Notification 2024 | 2024-01-26 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Sana Biotechnology, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32303/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32303 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32303 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32303 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32303}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sana Biotechnology, Inc. (id: 32303)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.